In a meta-analysis of randomized controlled trials on human subjects, a combination of valsartan and lipoic acid increased SOD levels and decreased MDA, countering OxSt and lowering albuminuria in DN patients more significantly than either of the components in monotherapy [198]. Here, SOD1 is linked to liver dysplastic nodule.